Nutrition & Care Q1 2019 First-quarter sales in the Nutrition & Care segment matched the prior-year level. Considerably higher sales in the Nutrition & Health division were offset by slightly lower sales in the Care Chemicals division. (XLS:) Download Factors influencing sales in Q1 2019 – Nutrition & Care Nutrition & Care Care Chemicals Nutrition & Health Volumes (1%) (6%) 13% Prices (1%) 0% (5%) Portfolio 0% 0% 0% Currencies 2% 2% 2% Sales 0% (4%) 10% Positive currency effects, especially relating to the U.S. dollar, increased sales slightly in both divisions. By contrast, sales were negatively impacted by lower prices, especially in the Nutrition & Health division’s animal nutrition business. Sales volumes also declined slightly overall. Sales volumes in the Care Chemicals division decreased significantly, mainly as a result of lower volumes in the home care, industrial and institutional cleaning, and industrial formulators business. By contrast, the Nutrition & Health division considerably increased sales volumes, primarily due to higher volumes of aroma ingredients as a result of significantly improved product availability from our plants in Ludwigshafen, Germany, and Kuantan, Malaysia. Income from operations (EBIT) before special items was considerably below the figure for the first quarter of 2018. This was mainly attributable to higher fixed costs in the Nutrition & Health division, largely due to an insurance refund received in the prior-year quarter for production outages in 2017. In addition, margins declined in the animal nutrition business; as a result, earnings in the Nutrition & Health division decreased significantly overall. A considerable improvement in earnings in the Care Chemicals division, mainly from higher margins, had an offsetting effect. EBIT included an impairment in connection with the optimization of production sites within the Nutrition & Health division in Europe. (XLS:) Download Segment data – Nutrition & Care (Million €) Q1 2019 2018 +/– a Amortization of intangible assets and depreciation of property, plant and equipment (including impairments and reversals of impairments) b Additions to intangible assets and property, plant and equipment Sales to third parties 1,561 1,568 0% of which Care Chemicals 1,095 1,144 (4%) Nutrition & Health 466 424 10% Income from operations before depreciation, amortization and special items 327 346 (5%) Income from operations before depreciation and amortization (EBITDA) 320 340 (6%) Depreciation and amortizationa 196 92 113% Income from operations (EBIT) 124 248 (50%) Special items (98) (6) . EBIT before special items 222 254 (13%) Assets (March 31) 6,435 5,970 8% Investments including acquisitionsb 99 42 136% Research and development expenses 35 33 6% back next